Gut Repair Protocol
GI healing, gut lining repair, inflammation reduction, and microbiome support
Peptide Stack
Preparation
Reconstitute all peptides with bacteriostatic water. BPC-157 can be taken orally or injected subcutaneously. KPV and LL-37 are injected subcutaneously. Store at 2-8°C.
Administration
BPC-157 twice daily (oral or subcutaneous). KPV daily (subcutaneous). LL-37 twice weekly (subcutaneous). For oral BPC-157, take on empty stomach. Rotate injection sites if injecting.
Monitoring
Track digestive symptoms, bowel movements, abdominal pain, bloating, and overall gut comfort daily. Most users report improvements within 1-2 weeks. Continue for full 8 weeks for deep healing.
Expected Timeline
Week 1-2: Reduced acute inflammation and pain. Week 3-4: Improved gut lining integrity and reduced symptoms. Week 5-8: Continued mucosal healing and microbiome balance. Maintain results with diet and lifestyle.
Research Basis
BPC-157 is the cornerstone for mucosal healing with extensive GI research. KPV provides anti-inflammatory action via alpha-MSH pathway. LL-37 offers antimicrobial defense. Together, they address multiple aspects of gut health.
Safety Considerations
- Generally very well tolerated
- Avoid during pregnancy or breastfeeding
- Monitor for changes in bowel habits
- Combine with gut-friendly diet for best results
- Consult with a healthcare professional before starting
- This protocol is for research and educational purposes only
Protocol Overview
A GI-focused healing protocol for gut lining repair, inflammation reduction, and microbiome support. BPC-157 is the cornerstone for mucosal healing, supported by KPV's anti-inflammatory action and LL-37's antimicrobial defense.
Duration: 8 weeks Peptides: 3 Experience Level: Beginner
Peptide Stack
BPC-157
- Dose: 250-500 mcg
- Frequency: twice daily
- Timing: morning and evening
KPV
- Dose: 500 mcg
- Frequency: daily
- Timing: morning
LL-37
- Dose: 2-5 mg
- Frequency: twice weekly
- Timing: any time of day
Preparation
Reconstitute all peptides with bacteriostatic water. BPC-157 can be taken orally or injected subcutaneously. KPV and LL-37 are injected subcutaneously. Store at 2-8°C.
Administration
BPC-157 twice daily (oral or subcutaneous). KPV daily (subcutaneous). LL-37 twice weekly (subcutaneous). For oral BPC-157, take on empty stomach. Rotate injection sites if injecting.
Monitoring
Track digestive symptoms, bowel movements, abdominal pain, bloating, and overall gut comfort daily. Most users report improvements within 1-2 weeks. Continue for full 8 weeks for deep healing.
Expected Timeline
Week 1-2: Reduced acute inflammation and pain. Week 3-4: Improved gut lining integrity and reduced symptoms. Week 5-8: Continued mucosal healing and microbiome balance. Maintain results with diet and lifestyle.
Research Basis
BPC-157 is the cornerstone for mucosal healing with extensive GI research. KPV provides anti-inflammatory action via alpha-MSH pathway. LL-37 offers antimicrobial defense. Together, they address multiple aspects of gut health.
Safety Considerations
- Generally very well tolerated
- Avoid during pregnancy or breastfeeding
- Monitor for changes in bowel habits
- Combine with gut-friendly diet for best results
- Consult with a healthcare professional before starting
- This protocol is for research and educational purposes only
Disclaimer: This protocol is for educational and research purposes only. It is not medical advice. Consult with a qualified healthcare professional before starting any peptide protocol. These compounds are not approved by the MHRA for human therapeutic use.
Important Disclaimer: This protocol is for educational and research purposes only. It is not medical advice. Consult with a qualified healthcare professional before starting any peptide protocol. These compounds are not approved by the MHRA for human therapeutic use.